Carol L. Karp, MD describes the treatment of ocular surface tumors in an interview with David Goldman, MD. Ocular surface tumors can be put into three categories: pigmented, non-pigmented and lymphomas. Ocular squamous neoplasias (which used to be ca…
Winfried Amoaku, MD Outlines Retina Treatments in the UK
In an interview with retina specialist Sophie Bakri, MD of the Mayo Clinic, Dr. Winfried Amoaku discusses ophthalmology in the context of the UK’s National Health System.
Treatments for macular degeneration in the UK: offering laser treatment for ex…
Samuel C.Yiu, MD, PhD, Discusses Cornea Transplantation Surgery and Dry Eye
Dr. Yiu provides an update on a variety of anterior segment issues in a conversation with Dr. Brian Francis.
The DMEK procedure: DMEK = Descemet’s membrane only, no stromal tissue. It is relatively new with few surgeons actually skilled in the techn…
Where’s the Stethoscope?: An Orbital AVM Case Report
Featured Article
Vikas Chopra, MD, Discusses Methods for Characterizing the RNFL in Glaucoma
The structure of the optic nerve indicates its function. This fits with the definition of glaucoma: a progressive optic neuropathy with functional vision loss. EMGT and OHTS studies both show that early detection and treatment can preserve vision. …
Dr. Cedric Francois Discusses the Complement C3 Inhibitor POT-4 for AMD
Cedric Francois MD, PhD, President/CEO of Potentia Pharmaceuticals describes his company’s novel anti-AMD compound (POT-4) in a conversation with Dr. Sophie Bakri.
After trying many approaches, complement inhibition was viewed as being the best way t…